Title:
NOVEL PHARMACEUTICAL COMPOSITION
Document Type and Number:
WIPO Patent Application WO/2023/149549
Kind Code:
A1
Abstract:
A purpose of the present invention is to provide a novel pharmaceutical composition, particularly a novel anti-cancer pharmaceutical composition, and a novel compound used for the anti-cancer agent. The present invention provides a pharmaceutical composition including, as an active ingredient, a compound represented by the formula (I) below or a pharmacologically acceptable salt thereof.
More Like This:
| WO/2013/143466 | SUBSTITUTED PYRIMIDINE DERIVATIVE AS AURORA KINASE INHIBITOR |
| JP2012509916 | Benzodiazepine compounds used as inhibitors of otaxins |
| WO/2021/016102 | INHIBITORS OF TYROSINE KINASE |
Inventors:
AWALE SURESH (JP)
TOYOOKA NAOKI (JP)
TOYOOKA NAOKI (JP)
Application Number:
PCT/JP2023/003581
Publication Date:
August 10, 2023
Filing Date:
February 03, 2023
Export Citation:
Assignee:
NATIONAL UNIV CORPORATION UNIV OF TOYAMA (JP)
International Classes:
A61P35/00; A61K31/343; C07D307/80; C07D307/83
Foreign References:
| US20140128460A1 | 2014-05-08 | |||
| JP2019524747A | 2019-09-05 | |||
| CN102718735A | 2012-10-10 | |||
| JP2002514636A | 2002-05-21 | |||
| JP2013539757A | 2013-10-28 |
Other References:
BOGNAR ZITA, FEKETE KATALIN, ANTUS CSENGE, HOCSAK ENIKO, BOGNAR RITA, TAPODI ANTAL, BORONKAI ARPAD, FARKAS NELLI, GALLYAS FERENC, : "Desethylamiodarone—A metabolite of amiodarone—Induces apoptosis on T24 human bladder cancer cells via multiple pathways", PLOS ONE, vol. 12, no. 12, 8 December 2017 (2017-12-08), pages e0189470, XP093083345, DOI: 10.1371/journal.pone.0189470
Attorney, Agent or Firm:
IP FIRM SHUWA (JP)
Download PDF: